ISMPP Highlights
Author Selection Practices Recommended by ISMPP Authorship Task Force – Now Published in CMRO
Author selection based on ICMJE criterion 1 can be challenging, particularly for multicenter trials with a large number of investigators and contributors. The ISMPP Authorship Task Force was formally launched in 2019 to define author selection best practices for industry-sponsored medical publications. The recommendations were published in CMRO on April 19, 2022…
“In The Know” – Key Updates in Medical Communications
“In The Know” highlights various updates in medical publications and communications: New CHEERS 2022 Guidance, Preprints in ICMJE Recommendations, Carbon Costs of In-Person vs Virtual Medical Conferences, Readability and Format of PLS, AI-Assisted Tools in Scholarly Communications, Peer Review Congress in September 2022…
GPP4 – The Latest Update as Interest Grows
Excitement is building as the fourth iteration of the Good Publication Practice (also known as GPP4) guidance nears completion. At the 2022 European Meeting of ISMPP in late January, Dan Bridges (CEO, Nucleus Global) of the GPP4 Steering Committee presented information on the team’s progress. Watch the video to view this GPP4 update…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Tactical Delivery of Medical Publications: A Visual Journey
Are you interested in guidance on the processes behind drafting and developing medical publications? View a stepwise visual guide on tactical delivery of medical publications that considers the roles and responsibilities of key stakeholders, best practices and how to adhere to industry standards, roles of pharma publication and agency teams, and more…
Developing a Strategic Publication Plan: A Visual Survival Kit
Developing a strategic publication plan is vital to ensuring that key audiences can access the information they need to understand the potential benefits of a pharmaceutical product. View a stepwise visual guide on how to approach the development of a strategic publication plan and guidance around how it can then be assessed and adapted…
Getting Started: Social Media and Scientific Communications
Healthcare professionals are increasingly using social media to find relevant information that informs their practice. Alongside researchers and publishers, the pharmaceutical and biotechnology industries have a responsibility to provide healthcare professionals with trustworthy, timely and accurate scientific data about the products they research and develop, and the diseases they treat…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
Unintended Submission to a Predatory Journal – Oh No!
You are a medical publication professional and have been supporting a client with a secondary manuscript for a Phase 3 study. You recommended target journals and worked with the author team throughout the submission process. Following the publication, it becomes apparent that the manuscript was submitted to a predatory journal…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals